The global Medical Imaging Reagents Market is estimated to be valued at US$ 11.21 Bn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Medical imaging reagents are contrast enhancing agents used for improving the visual quality of images during various medical imaging procedures. These reagents help reveal internal structures and body processes to diagnose and monitor treatment of diseases. They are helpful tools to understand the functioning of different body organs and identify specific areas requiring medical attention.
Market key trends:
One of the key trends in the medical imaging reagents market is continuous innovations in contrast agents. Companies are developing advanced contrast agents using nano-particles and targeted ligands for enhanced molecular imaging. Such targeted medical imaging agents can accurately reveal specific biological processes at molecular and cellular levels. They enable precise diagnosis of conditions at early stages and facilitate non-invasive monitoring of treatment responses. However, rising healthcare costs and strict regulatory approvals remain challenges for growth of innovations in this space.
Segment Analysis:
The global medical imaging reagents market can be segmented into diagnostic reagents and contrast reagents. Diagnostic reagents dominate the market and account for the largest market share. Within diagnostic reagents, immunochemistry reagents are the most commonly used reagents for disease diagnostics. Immunoassays such as enzyme-linked immunosorbent assay (ELISA) and western blot are widely used techniques for disease diagnosis, which has propelled the growth of the immunochemistry reagents segment.
Key Takeaways:
The Global Medical Imaging Reagents Market Growth is expected to witness high, exhibiting CAGR of 5.0% over the forecast period, due to increasing prevalence of chronic and lifestyle diseases.
Regional analysis:
North America holds the highest share in the medical imaging reagents market majorly due to availability of advanced healthcare infrastructure and growing adoption of medical imaging procedures in the region. Asia Pacific is expected to grow at the fastest pace during the forecast period owing to improving healthcare infrastructure and increasing healthcare expenditure in major Asian countries like China and India.
Key players:
Key players operating in the medical imaging reagents market are Bayer AG, Bracco SpA, Eli Lilly and Company, General Electric Company (GE Healthcare), among others. Bayer AG is one of the leading players in the market and offers a wide range of contrast and diagnostic reagents for various medical imaging modalities like X-ray, MRI, ultrasound etc.
The global medical imaging reagents market size for 2023 is US$ 11.21 Bn. The market is anticipated to grow at a CAGR of 5.0% during the forecast period of 2023 to 2030.
Read More -
https://www.trendingwebwire.com/medical-imaging-reagents-market-share-and-size-analysis/
